Sir,

^18^F-fluorodeoxyglucose positron emission tomography-computed tomography (^18^F-FDG PET-CT) has now become the imaging modality of choice for high-grade lymphomas. Being a highly sensitive whole-body metabolic imaging technique, it can demonstrate unusual sites of involvement in these patients, which could be otherwise missed. We present such a case here. A 65-year-old male presented with cervical lymphadenopathy along with progressive weakness, weight loss, and fatigue. Biopsy from the cervical node confirmed diffuse large B-cell lymphoma (DLBCL). A staging contrast-enhanced ^18^F-FDG PET-CT was performed. ^18^F-FDG PET-CT \[Figure [1a](#F1){ref-type="fig"}--[e](#F1){ref-type="fig"}\] showed lymph nodal involvement on both sides of diaphragm along with splenic involvement. Also noted was hypermetabolic right breast nodule suggesting involvement \[Figure [1a](#F1){ref-type="fig"}--[e](#F1){ref-type="fig"}, bold arrow\]. Maximum standardized uptake value of this lesion was 6.2. Based on ^18^F-FDG PET-CT findings, a diagnosis of stage IVBE DLBCL was made. A clinical examination was done thereafter which revealed bilateral age-related gynecomastia, firmer and slightly tender on right side, further supporting the diagnosis. The patient was started on rituximab-cyclophosphamide-doxorubicin-vincristine-prednisolone chemotherapy but was lost to follow-up after two cycles.

![Maximum intensity projection PET image (a) showing hypermetabolic lymphadenopathy both above and below the diaphragm (broken arrows), along with hypermetabolic splenomegaly (arrowhead). Also noted was focal^18^-FDG uptake in right anterior chest wall (bold arrow). Transaxial and sagittal CT and PET-CT (b-e) images of the thorax showing focal hypermetabolism involving right breast nodule measuring 17 mm × 15 mm, suggesting involvement (bold arrow). ^18^F-FDG PET-CT: ^18^F-fluorodeoxyglucose positron emission tomography-computed tomography](IJNM-32-249-g001){#F1}

Breast involvement in lymphoma could be either primary or secondary with latter being more common.\[[@ref1]\] Lymphoma accounts for \< 0.5% of all breast malignancies. Hence, lymphoma of male breast is even rarer.\[[@ref2]\] In these patients, it can present with gynecomastia.\[[@ref3]\] DLBCL is the most common histopathological subtype.\[[@ref4]\] Management is with chemotherapy and adjuvant radiotherapy when required while surgery has no definite role.\[[@ref5]\] As for lymphoma of other sites, ^18^F-FDG PET-CT plays an important role in the management of primary and secondary breast lymphoma.\[[@ref6][@ref7]\] In the present case, while the patient had bilateral gynecomastia clinically, lymphomatous involvement was only seen in right breast. This case reiterates the importance of ^18^F-FDG PET-CT in the management of patients with high-grade lymphoma by demonstrating usual sites of involvement.

Financial support and sponsorship {#sec2-1}
=================================

Nil.

Conflicts of interest {#sec2-2}
=====================

There are no conflicts of interest.
